Sen. Shaheen Issues Statement on President Trump’s Prescription Drug Price Proposal
"Due to soaring costs, many Americans are unable to afford prescriptions that are critical to their health and well-being. Though I'm glad to hear the President address prescription drug costs, I'm very disappointed that his proposal fails to include Medicare price negotiation. This is an enormous missed opportunity to make medications for millions of Americans more affordable.
"Allowing Medicare to negotiate lower prices with manufacturers would help make medication for chronic conditions like diabetes and high blood pressure more affordable for patients for whom access to prescription medications can be a matter of life and death. Allowing direct drug price negotiation by Medicare could help improve the affordability and accessibility of naloxone, an opioid overdose reversal drug that is essential to saving lives in
Providing more direct tools to address drug pricing could also help alleviate the growing pressure that Medicare Part D prescription drug costs are placing on the federal budget. According to the
Shaheen has long fought to combat rising drug prices, which hurt every day Americans struggling to afford the medication they need, as well as first responders in
W.Va. Supreme Court of Appeals Issues Decision Regarding Edward, Teresa Baez V. Foremost Insurance
Rep. Welch Issues Statement on President Trump’s Prescription Drug Proposal
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News